Patents-Review.com
🔗 Permalink
Assignee profile:

CURETECH LTD.

City:

Yavne

Country:

Israel

Published Applications:

11

Last publication date:

2017-02-28

Patent Grants:

11

Last grant date:

2017-02-28

Top Inventors for applications by CURETECH LTD.

These are the the leading inventors for applications assigned to CURETECH LTD.:

Recent patent applications by CURETECH LTD.

CURETECH LTD. based in Yavne, IL has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2017-02-28 ✅ Patent 9,580,504 granted on 2017-02-28
US14536343
Chemistry; metallurgy

Pidilizumab monoclonal antibody therapy following stem cell transplantation

 #2 | 2014-10-09 ✅ Patent 9,309,308 granted on 2016-04-12
US20140302032A1
Chemistry; metallurgy

Monoclonal antibodies for tumor treatment

 #3 | 2014-08-07 ✅ Patent 9,416,175 granted on 2016-08-16
US20140220010A1
Chemistry; metallurgy

Variants of humanized immunomodulatory monoclonal antibodies

 #4 | 2013-01-24 ✅ Patent 8,686,119 granted on 2014-04-01
US20130022595A1
Human necessities

Variants of humanized immunomodulatory monoclonal antibodies

 #5 | 2011-05-19 ✅ Patent 8,747,847 granted on 2014-06-10
US20110117085A1
Chemistry; metallurgy

Monoclonal antibodies for tumor treatment

 #6 | 2009-10-22 ✅ Patent 7,981,416 granted on 2011-07-19
US20090263386A1
Chemistry; metallurgy

Humanized immunomodulatory monoclonal antibodies for the treatment of immunodeficiency

 #7 | 2008-07-24 ✅ Patent 7,745,397 granted on 2010-06-29
US20080175855A1
Chemistry; metallurgy

Peptide useful in immunomodulation

 #8 | 2008-01-31 ✅ Patent 7,524,498 granted on 2009-04-28
US20080025980A1
Chemistry; metallurgy

Human immunomodulatory monoclonal antibodies for the treatment of cancer

 #9 | 2006-09-21 ✅ Patent 7,329,639 granted on 2008-02-12
US20060210573A1
Chemistry; metallurgy

Peptide useful in immunomodulation

 #10 | 2005-08-18 ✅ Patent 7,332,582 granted on 2008-02-19
US20050180969A1
Chemistry; metallurgy

Humanized immunomodulatory monoclonal antibodies for the treatment of neoplastic disease or immunodeficiency

 #11 | 2005-01-06 ✅ Patent 7,122,372 granted on 2006-10-17
US20050003397A1
Chemistry; metallurgy

Peptide useful in immunomodulation

Also check out CURETECH LTD.'s (Yavne, Israel) applicant profile with 3 patent applications submitted.

AssigneeID:

5857 ⎘